MVIR:STO
Medivir AB
၁.၄၈ SEK
arrow_downward
-၁.၈၆%(-၀.၀၂၈) 1D
အောက် ၁၃, GMT+၂ ၁၂:၂၉:၀၀ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
၁.၅၀ SEK
High
၁.၅၁ SEK
Low
၁.၄၈ SEK
Mkt. cap
၉၂.၅၀ ကုဋေ
Avg. vol.
၁.၄၆ သန်း
Volume
၃.၆၆ သိန်း
52-wk high
၂.၈၈ SEK
52-wk low
၀.၃၄ SEK
EPS
-၀.၃၇ SEK
Shares outstanding
၆၂.၄၂ ကုဋေ
No. of employees
၆
Open
၁.၅၀ SEK
High
၁.၅၁ SEK
Low
၁.၄၈ SEK
Mkt. cap
၉၂.၅၀ ကုဋေ
Avg. vol.
၁.၄၆ သန်း
Volume
၃.၆၆ သိန်း
52-wk high
၂.၈၈ SEK
52-wk low
၀.၃၄ SEK
EPS
-၀.၃၇ SEK
Shares outstanding
၆၂.၄၂ ကုဋေ
No. of employees
၆
News stories
From web sources and news partners
marketscreener.com
·
ပြီးခဲ့သည့် ၇ မိနစ်
S&P 500 futures muted as investors await big bank earnings; chip weakness weighs
The Motley Fool
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
Prediction: A Stock Market Crash Is Coming. Here's What Investors Should Do Based on Almost 7 Decades' Worth of History.
ChartMill
·
ပြီးခဲ့သည့် ၁ နာရီ
Royal Gold (NASDAQ:RGLD): A Dividend Quality Profile for Income Investors
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
US Stock Futures Mixed as AI Concerns, LVMH Sales and Bank Earnings Shape Market Sentiment: Dow Jones, S&P, Nasdaq, Wall Street
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB